BIT
Click for more information
3.03% 3.4¢ biotron limited

Novavax to commence COVID-19 vaccine trial with Nucleus...

  1. clayzee
    7 Posts.
    lightbulb Created with Sketch. 8
    clock Created with Sketch.
    15/04/20
    20:45
    Post #: 44064056

    Novavax to commence COVID-19 vaccine trial with Nucleus Network

    15th April 2020

    US-based clinical-stage biotechnology company Novavax (NASDAQ: NVAX) has called upon the expertise of Australian based Nucleus Network (Nucleus) to commence Phase 1 clinical trials for its COVID-19 vaccine trials.


    Beaten to the punch?


    Last edited by clayzee: 15/04/20
    BIT Price at posting: 10.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ASL Andean discovers up to 4,649 AgEq through maiden drilling in Chile
right-arrow Created with Sketch.
NRX Noronex joins forces with South32 to look for copper in Namibia
right-arrow Created with Sketch.
WGX Australian foreign investment regulators greenlight Westgold's buyout of Karora
right-arrow Created with Sketch.
AMI First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia
right-arrow Created with Sketch.
AGY Argosy signs deal to sell battery-grade Rincon lithium to Korea
right-arrow Created with Sketch.
ABY Adore Beauty FY24 revenues up 7.4% YoY to $196M
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.4¢ 		Change
0.001(3.03%) 		Mkt cap ! $30.67M
Open High Low Value Volume
3.4¢ 3.4¢ 3.3¢ $632 18.85K

Buyers (Bids)

No. Vol. Price($)
1 287617 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 37989 2
View Market Depth
Last trade - 13.36pm 19/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.